Lipophilic methylene violet analogues as modulators of mitochondrial function and dysfunction

Area of Science:

• Medicinal Chemistry
• Biochemistry
• Neuroscience

Background:

• Oxidative stress is a key factor in neurodegenerative diseases, including Friedreich's ataxia (FRDA).
• Methylene blue and its analogues are known for their antioxidant potential.
• Developing improved antioxidants is crucial for therapeutic interventions.

Purpose of the Study:

• To design and synthesize novel methylene violet analogues with enhanced antioxidant activity.
• To evaluate the efficacy of these analogues in preserving mitochondrial function in FRDA lymphocytes.

Main Methods:

• Synthesis of new methylene violet analogues using an efficient route involving Smiles rearrangement.
• Evaluation of analogues' ability to scavenge reactive oxygen species (ROS).
• Assessment of mitochondrial function, including membrane potential and ATP production, in FRDA lymphocytes.

Main Results:

• The synthesized methylene violet analogues exhibited potent ROS scavenging capabilities.
• Analogues effectively protected FRDA lymphocytes from oxidative stress induced by Complex I inhibition.
• Mitochondrial membrane potential was preserved, and ATP production was augmented by the analogues.

Conclusions:

• The novel methylene violet analogues are more effective antioxidants than methylene blue and methylene violet.
• These compounds demonstrate significant potential for mitigating oxidative stress in FRDA and related conditions.
• The developed synthetic route offers improved yield and purity for analogue production.